Work

Abstract LB129: Preclinical development of a bispecific antibody-trap selectively targeting CD38 and CD47 for treating hematologic malignancies

Year: 2024
Type: conference-abstract
Language: English
Subfield: Immunology
Open Access status: closed
OpenAlex ID: W4393987776
Cites:
Cited by: 1
Related to: 10